Variable number of tandem repeat polymorphisms of DRD4: Re-evaluation of selection hypothesis and analysis of association with schizophrenia

European Journal of Human Genetics

Volumn 17, Issue 6, 2009, Pages 793-801

  Hattori, Eiji ^a   Nakajima, Mizuho ^a   Yamada, Kazuo ^a   Iwayama, Yoshimi ^a   Toyota, Tomoko ^a   Saitou, Naruya ^b   Yoshikawa, Takeo ^a,c  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b NATIONAL INSTITUTE OF GENETICS   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 4 RECEPTOR;

ADULT; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC DRIFT; GENETIC POLYMORPHISM; GENETIC SELECTION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PLESIOMORPHY; PRIORITY JOURNAL; SCHIZOPHRENIA; VARIABLE NUMBER OF TANDEM REPEAT;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETICS, POPULATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D4; SCHIZOPHRENIA; TANDEM REPEAT SEQUENCES;

PAN;

EID: 67349148888     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.247     Document Type: Article

References (49)

1. Prasad S, Semwal P, Deshpande S, Bhatia T, Nimgaonkar VL, Thelma BK: Molecular genetics of schizophrenia: Past, present and future. J Biosci 2002; 27: 35-52.
2. Petronis A, Van Tol HH, Lichter JB, Livak KJ, Kennedy JL: The D4 dopamine receptor gene maps on 11p proximal to HRAS. Genomics 1993; 18: 161-163.
3. Gelernter J, Kennedy JL, Van Tol HH, Civelli O, Kidd KK: The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics 1992; 13: 208-210.
4. Sanyal S, Van Tol HH: Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action. J Psychiatr Res 1997; 31: 219-232.
5. Van Tol HH, Bunzow JR, Guan HC et al: Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991; 350: 610-614.
6. Stefanis NC, Bresnick JN, Kerwin RW, Schofield WN, McAllister G: Elevation of D4 doparnine receptor mRNA in postmortem schizophrenic brain. Brain Res Mol Brain Res 1998; 53: 112-119.
7. 3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Brain Res 1995; 681: 109-116.
8. Murray AM, Hyde TM, Knable MB et al: Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci 1995; 15: 2186-2191.
9. Seeman P, Guan HC, Van Tol HH: Dopamine D4 receptors elevated in schizophrenia. Nature 1993; 365: 441-445.
10. Van Tol HH, Wu CM, Guan HC et al: Multiple dopamine D4 receptor variants in the human population. Nature 1992; 358: 149-152.
11. Schoots O, Van Tol HH: The human dopamine D4 receptor repeat sequences modulate expression. Pharmacogenomics J 2003; 3: 343-348.
12. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH: Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995; 65: 1157-1165.
13. Jonsson E, Brene S, Geijer T et al: A search for association between schizophrenia and dopamine-related alleles. Eur Arch Psychiatry Clin Neurosci 1996; 246: 297-304.
14. Ebstein RP, Novick O, Umansky R et al: Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet 1996; 12: 78-80.
15. Faraone SV, Doyle AE, Mick E, Biederman J: Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001; 158: 1052-1057.
16. LaHoste GJ, Swanson JM, Wigal SB et al: Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1: 121-124.
17. Sanak M, Zelek-Molik A, Nalepa I, Wegrzyn J, Wciorka J: The dopamine D4 receptor VNTR in Polish schizophrenia patients. Schizophr Res 2005; 73: 129-131.
18. Ambrosio AM, Kennedy JL, Macciardi F et al: No evidence of association or linkage disequilibrium between polymorphisms in the 5′ upstream and coding regions of the dopamine D4 receptor gene and schizophrenia in a Portuguese population. Am J Med Genet B Neuropsychiatr Genet 2004; 125: 20-24.
19. Segman RH, Goltser T, Heresco-Levy U et al: Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia. Pharmacogenomics J 2003; 3: 277-283.
20. Tang Y, Wang Y, Cai Z: [Schizophrenia and dopamine D4 gene polymorphism in Chinese population: Association analysis]. Zhonghua Yi Xue Za Zhi 2001; 81: 995-998.
21. Serretti A, Lilli R, Lorenzi C, Lattuada E, Smeraldi E: DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: A study on 2,011 affected subjects. Am J Med Genet 2001; 105: 283-290.
22. Kaiser R, Konneker M, Henneken M et al: Dopamine D4 receptor 48-bp repeat polymorphism: No association with response to antipsychotic treatment, but association with catatonic schizophrenia. Mol Psychiatry 2000; 5: 418-424.
23. Serretti A, Lilli R, Di Bella D et al: Dopamine receptor D4 gene is not associated with major psychoses. Am J Med Genet 1999; 88 486-491.
24. Hwu HG, Hong Q, Lee YL, Lee PC, Lee SF: Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia. Biol Psychiatry 1998; 44: 483-487.
25. Kohn Y, Ebstein RP, Heresco-Levy U et al: Dopamine D4 receptor gene polymorphisms: Relation to ethniciM no association with schizophrenia and response to clozapine in Israeli subjects. Eur Neuropsychopharmacol 1997; 7: 39-43.
26. Hong QJ, Lee YL, Sim CB, Hwu HG: Doparnine D4 receptor variants in Chinese sporadic and familial schizophrenics. Am J Med Genet 1997; 74: 412-415.
27. Weiss J, Magert HJ, Cieslak A, Forssmann WG: Association between different psychotic disorders and the DRD4 polymorphism, but no differences in the main ligand binding region of the DRD4 receptor protein compared to controls. Eur J Med Res 1996; 1: 439-445.
28. Petronis A, Macciardi F, Athanassiades A et al: Association study between the dopamine D4 receptor gene and schizophrenia. Am J Med Genet 1995; 60: 452-455.
29. Daniels J, Williams J, Mant R, Asherson P, McGuffin P, Owen MJ: Repeat length variation in the dopamine D4 receptor gene shows no evidence of association with schizophrenia. Am J Med Genet 1994; 54: 256-258.
30. Sommer SS, Lind TJ, Heston LL, Sobell JL: Dopamine D4 receptor variants in unrelated schizophrenic cases and controls. Am J Med Genet 1993; 48: 90-93.
31. Nanko S, Hattori M, Ikeda K, Sasaki T, Kazamatsuri H, Kuwata S: Dopamine D4 receptor polymorphism and schizophrenia. Lancet 1993; 341 689-690.
32. Iwata Y, Matsumoto H, Minabe Y et al: Early-onset schizophrenia and dopamine-related gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 2003; 116: 23-26.
33. Tanaka T, Igarashi S, Onodera O et al: Lack of association between dopamine D4 receptor gene and schizophrenia. Am J Med Genet 1995; 60: 580-582.
34. Wang E, Ding YC, Flodman P et al: The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. Am J Hum Genet 2004; 74: 931-944.
35. Ding YC, Chi HC, Grady DL et al: Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proc Natl Acad Sci USA 2002; 99: 309-314.
36. Bandelt HJ: Phylogenetic networks. Verh Naturewiss Ver Hamburg (NF) 1994; 34: 51-71.
37. Saitou N, Yamamoto F: Evolution of primate ABO blood group genes and their homologous genes. Mol Biol Evol 1997; 14: 399-411.
38. Shimizu H, Iwayarna Y, Yamada K et al: Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia. Schizophr Res 2006; 84: 244-252.
39. Aoki-Suzuki M, Yamada K, Meerabux J et al: A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia. Biol Psychiatry 2005; 57: 382-393.
40. Sham PC, Curtis D: Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995; 59 (Pt 1): 97-105.
41. Martin ER, Monks SA, Warren LL, Kaplan NL: A test for linkage and association in general pedigrees: The pedigree disequilibrium test. Am J Hum Genet 2000; 67: 146-154.
42. Kim YS, Leventhal BL, Kim SJ et al: Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD. Neurosci Lett 2005; 390: 176-181.
43. Livak KJ, Rogers J, Lichter JB: Variability of dopamine D4 receptor (DRD4) gene sequence within and among nonhuman primate species. Proc Natl Acad Sci USA 1995; 92: 427-431.
44. Gelernter J, Kranzler H, Coccaro E, Siever L, New A, Mulgrew CL: D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. Am J Hum Genet 1997; 61: 1144-1152.
45. Nakajima T, Wooding S, Sakagami T et al: Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world. Am J Hum Genet 2004; 74: 898-916.
46. Glatt SJ, Faraone SV, Tsuang MT: Schizophrenia is not associated with DRD4 48-base-pair-repeat length or individual alleles: Results of a meta-analysis. Biol Psychiatry 2003; 54: 629-635.
47. Nakajima M, Hattori E, Yamada K et al: Association and synergistic interaction between promoter variants of the DRD4 gene in Japanese schizophrenics. J Hum Genet 2007; 52: 86-91.
48. Pritchard JK, Stephens M, Donnelly P: Inference of population structure using multilocus genotype data. Genetics 2000; 155: 945-959.
49. Purcell S, Cherny SSD Sham PC: Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.